Chapter 1: Curcumin is excellent compound for various medicinal usages

Size: px
Start display at page:

Download "Chapter 1: Curcumin is excellent compound for various medicinal usages"

Transcription

1 Super-Curcumin Story Chapter 1: Curcumin is excellent compound for various medicinal usages Chapter 2: Discovery of Super-Curcumin analog Chapter 3: Anti-tumor activities of Super-Curcumin analog Chapter 4: Molecular targets of analogs Chapter 5: Oncogenes & analogs Chapter 6: Apoptosis & analogs Chapter 7: Cancer stem cells & analogs Chapter 8: Analogs lead drug discovery Supplement: Super-Curcumin analog & Sleeping sickness (African trypanosomiasis)

2 Chapter 1: Curcumin is excellent compound for various medicinal usages Curcumin We can eat it! IUPAC name; (1E,6E)-1,7-bis (4-hydroxy-3-methoxyphenyl) -1,6- heptadiene-3,5-dione Curcumin is a multi-targeted compound Defeat all enemies! Cur Curcumin can stop the individual gears of wheels in cancer. Curcumin man

3 Why does curcumin have a multiplicity of targets? Michael reaction High affinity to proteins via a thiol group Protein

4 How can curcumin control multiple targets? Resilience Pros Cons curcumin Well balanced Healthy Pros Cons Molar ratio Ex) Anti oncogene Th1 Ex) Oncogene Th2 Cancer Infection Inflammation Alzheimer Tumor immune tolerance Resilience Recovery of health

5 Chapter 2: Discovery of Super-Curcumin analog Collaborator; Dept. Organic Chemistry, Graduate School of Pharmaceutical Science Tohoku Univ. Analog screening was started from the chemical library stored in Dept., Organic Chem.

6 Chapter 3: Anti-tumor activities of Super-Curcumin analog 0 > spiecies of analogs types of cancer cell lines Over 100 species of analogs were synthesized from one lead compound, and the anti-tumor activities against 16 types of cancer cell lines were examined. Analogs can kill the cancer cells at concentrations times lower than 5-FU, cisplatin, irinotecan. Analogs bearing strong anti-tumor activities They have a 84 times stronger activity than Curcumin.

7 Chapter 4: Molecular targets of analogs Analogs have different mechanisms from approved cytotoxics. This structure is important. GO 035 IC 50 : 1.6 M Stronger anti-tumor activities >> GO Y041 IC 50 : >100 M No anti-tumor activities Michael reaction No affinity to High affinity to Targeted to Oncogene products (protein) DNA

8 Analogs target oncogene products. Malignant phenotypes 1. Loss of growth control 2. Resistance to apoptosis 3. Immortality 4. Angiogenesis 5. Invasion 6. Metasatasis Chapter 5: Oncogenes & analog Her2 inhibitor Myc inhibitor Analogs can regulate overexpressed oncogene products such as,,,. c-myc, KRAS, CyclinD1, ErbB2, β-catenin, COX-2,, (examined). KRAS inhibitor NF-kB inhibitor

9 Analogs can induce apoptosis. Malignant phenotypes Chapter 6: Apoptosis & analogs Caspases induction 1. Loss of growth control 2. Resistance to apoptosis 3. Immortality 4. Angiogenesis 5. Invasion 6. Metasatasis Analogs can induce apoptosis related proteins such as,,,,,,,. Caspases, PARP, TP53, XIAP, DR5,, (examined). P53 induction control curcumin GO-Y030 Death receptor induction Apoptotic DLD-1 cells

10 Analogs can kill cancer stem cells. Cancer stem cell is like a queen bee. She is resistant to chemotherapy. Chapter 7: Cancer stem cells & analogs sensitive resistant Killer Queen Phosphorylation of STAT3 is characteristic to cancer stem cells. Analogs can bind phosphorylation site of STAT3, and inhibit STAT3 signaling. Analog Analogs can inhibit cancer stem cell growth in vivo. STAT3

11 Chapter 8: Potential against rare cancers

12 CTCL can be cured in animal model.

13 Rare cancers Multiple myeloma MTT Assay 50.0 GI50(μM) RPMI8226 KMS12 U266 OPM Curcumin Y030 Y078 Melphalan Thalidomide 72hr treatment

14 Chapter 9: Anti-angiogenic potential of analogs

15 Chapter 10: Radioprotection

16 Chapter 11: 1. Improvement of solubility Curcumin is low bioavailable (insoluble in water, poor absorption).

17 2. Antibody-Drug Conjugate Antigen recognition site Papain digestion Michael addition reduction addition

18 Chapter 12: Future Directions 1. An analog was detected in curry. It is potent to suppress gastric cancer in vivo. control ** * * * * ** analog * * * * Functional Food 2. Analogs could induce anti-tumor immunity, like curcumin. curcumin Increase CD4+ & CD8+ Increase Th1 cytokines Decrease Treg Decrease T cell apoptosis

19 Apendix (1): Patent Right We got US and Japan patents. Analog Analog man

20 Appendix (2): Analog & Sleeping sickness (African trypanosomiasis) Analogs may be effective for trypanosomiasis (sleeping sickness). Growth inhibition carried by mosquitoes Analogs Anti-trypanosomia activity Cytotoxicity Safety Index Recruit Collaborators!!

UNIVERSITY TEKNOLOGI MARA THE ANTI PROLIFERATIVE PROPERTIES OF TINOSPORA CRISPA ON TRIPLE NEGATIVE BREAST CANCER CELL LINES

UNIVERSITY TEKNOLOGI MARA THE ANTI PROLIFERATIVE PROPERTIES OF TINOSPORA CRISPA ON TRIPLE NEGATIVE BREAST CANCER CELL LINES UNIVERSITY TEKNOLOGI MARA THE ANTI PROLIFERATIVE PROPERTIES OF TINOSPORA CRISPA ON TRIPLE NEGATIVE BREAST CANCER CELL LINES REYADH RADHI AL-RASHIDI Thesis submitted in fulfillment of the requirements for

More information

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis. Cancer Biology Chapter 18 Eric J. Hall., Amato Giaccia, Radiobiology for the Radiologist Introduction Tissue homeostasis depends on the regulated cell division and self-elimination (programmed cell death)

More information

T cell maturation. T-cell Maturation. What allows T cell maturation?

T cell maturation. T-cell Maturation. What allows T cell maturation? T-cell Maturation What allows T cell maturation? Direct contact with thymic epithelial cells Influence of thymic hormones Growth factors (cytokines, CSF) T cell maturation T cell progenitor DN DP SP 2ry

More information

C-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein. pigment isolated from Spirulina platensis. This water- soluble protein pigment is

C-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein. pigment isolated from Spirulina platensis. This water- soluble protein pigment is ' ^Summary C-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein pigment isolated from Spirulina platensis. This water- soluble protein pigment is of greater importance because of its various

More information

ciap using fragment based drug discovery

ciap using fragment based drug discovery Discovery of a potent dual antagonist of both XIAP and ciap using fragment based drug discovery Gianni Chessari, PhD TAT Congress 2012 Disclosures I am an employee of Astex Pharmaceuticals I will present

More information

Apoptosis Mediated Cytotoxicity of Curcumin Analogues PGV-0 and PGV-1 in WiDr Cell Line

Apoptosis Mediated Cytotoxicity of Curcumin Analogues PGV-0 and PGV-1 in WiDr Cell Line Apoptosis Mediated Cytotoxicity of Curcumin Analogues PGV-0 and PGV-1 in WiDr Cell Line Endah Puji Septisetyani, Muthi Ikawati, Barinta Widaryanti and Edy Meiyanto* ) Cancer Chemoprevention Research Center,

More information

Type of file: PDF Size of file: 0 KB Title of file for HTML: Supplementary Information Description: Supplementary Figures

Type of file: PDF Size of file: 0 KB Title of file for HTML: Supplementary Information Description: Supplementary Figures Type of file: PDF Size of file: 0 KB Title of file for HTML: Supplementary Information Description: Supplementary Figures Supplementary Figure 1 mir-128-3p is highly expressed in chemoresistant, metastatic

More information

Diseases of Immunity 2017 CL Davis General Pathology. Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc.

Diseases of Immunity 2017 CL Davis General Pathology. Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc. Diseases of Immunity 2017 CL Davis General Pathology Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc. Autoimmunity Reflects a loss of immunologic tolerance Mechanisms Auto-antibodies

More information

Innate Immunity, Inflammation and Cancer

Innate Immunity, Inflammation and Cancer Innate Immunity, Inflammation and Cancer Willem Overwijk, Ph.D. Melanoma Medical Oncology Center for Cancer Immunology Research MD Anderson Cancer Center, Houston, TX SITC/MDACC -6/14/2013 www.allthingsbeautiful.com

More information

Antiangiogenesis - Immune Therapy Combinations. George Coukos, MD, PhD Heinz Zwierzina, MD

Antiangiogenesis - Immune Therapy Combinations. George Coukos, MD, PhD Heinz Zwierzina, MD Antiangiogenesis - Immune Therapy Combinations George Coukos, MD, PhD Heinz Zwierzina, MD Overview Effect of VEGF on antitumor immune response Antigen presentation Effector mechanisms Ying and yang and

More information

Chemistry of Carbon. Building Blocks of Life

Chemistry of Carbon. Building Blocks of Life Chemistry of Carbon Building Blocks of Life 2013-2014 Why study Carbon? All of life is built on carbon Cells ~72% H 2 O ~25% carbon compounds carbohydrates lipids proteins nucleic acids ~3% salts Na, Cl,

More information

p53 and Apoptosis: Master Guardian and Executioner Part 2

p53 and Apoptosis: Master Guardian and Executioner Part 2 p53 and Apoptosis: Master Guardian and Executioner Part 2 p14arf in human cells is a antagonist of Mdm2. The expression of ARF causes a rapid increase in p53 levels, so what would you suggest?.. The enemy

More information

Immunology CANCER IMMUNOLOGY

Immunology CANCER IMMUNOLOGY Immunology د. عائدة الدرزي Lec. 6 CANCER IMMUNOLOGY Oncogenesis (passes through two stages): 1- Reversible change Normal transformed cells 2- Irreversible change Transformed oncogenic cells Factors causing

More information

BL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES. Overview and Mechanism of Action Dr.

BL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES. Overview and Mechanism of Action Dr. BL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES Overview and Mechanism of Action Dr. Leah Klapper, CSO 88 BL-8040: Novel CXCR4 Antagonist For Hematological Cancers Indications:

More information

Challenges in Establishing Potent Cancer Chemotherapy Using Newly Synthesized 1,5-Diaryl-3-Oxo-1,4- Pentadiene Analogs of Curcumin

Challenges in Establishing Potent Cancer Chemotherapy Using Newly Synthesized 1,5-Diaryl-3-Oxo-1,4- Pentadiene Analogs of Curcumin In: Curcumin: Biosynthesis, Medicinal Uses and Health Benefits ISBN: 978-1-61942-481-4 Editors: Jun Sasaki and Masaki Kichida 2012 Nova Science Publishers, Inc. The exclusive license for this PDF is limited

More information

Index. neurosurgery.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. neurosurgery.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A A Complimentary Trial of an Immunotherapy Vaccine Against Tumor-specific EGFRvIII (ACTIVATE), 90 91 Active immunotherapy, 5 8, 96. See

More information

CELL BIOLOGY - CLUTCH CH CANCER.

CELL BIOLOGY - CLUTCH CH CANCER. !! www.clutchprep.com CONCEPT: OVERVIEW OF CANCER Cancer is a disease which is primarily caused from misregulated cell division, which form There are two types of tumors - Benign tumors remain confined

More information

Journal Club: The Use of Fish Oil Lipid Emulsion for Gastrointestinal Surgery Patients

Journal Club: The Use of Fish Oil Lipid Emulsion for Gastrointestinal Surgery Patients S a m m i M o n t a g F i s h O i l E m u l s i o n J o u r n a l C l u b - P a g e 1 Journal Club: The Use of Fish Oil Lipid Emulsion for Gastrointestinal Surgery Patients Introduction/Background I. Surgical

More information

Micro RNA Research. Ken Kosik. Harriman Professor, Department of Molecular, Cellular & Developmental Biology and Biomolecular Sciences & Engr.

Micro RNA Research. Ken Kosik. Harriman Professor, Department of Molecular, Cellular & Developmental Biology and Biomolecular Sciences & Engr. Ken Kosik Harriman Professor, Department of Molecular, Cellular & Developmental Biology and Biomolecular Sciences & Engr. Program Co-Director, Neurosciences Research Institute Micro RNA Research Neuroscience

More information

EBV infection B cells and lymphomagenesis. Sridhar Chaganti

EBV infection B cells and lymphomagenesis. Sridhar Chaganti EBV infection B cells and lymphomagenesis Sridhar Chaganti How EBV infects B-cells How viral genes influence the infected B cell Differences and similarities between in vitro and in vivo infection How

More information

Developing Best in Class BET Inhibitors for Oncology & AI: from Discovery to the Clinic. Kevin G. McLure, PhD EpiCongress July 2014

Developing Best in Class BET Inhibitors for Oncology & AI: from Discovery to the Clinic. Kevin G. McLure, PhD EpiCongress July 2014 Developing Best in Class BET Inhibitors for Oncology & AI: from Discovery to the Clinic Kevin G. McLure, PhD EpiCongress July 2014 Zenith Epigenetics Overview Formed from Resverlogix as an independent

More information

IVC History, Cancer Research

IVC History, Cancer Research Riordan Clinic IVC Academy 5 IVC History, Cancer Research O (slides 41-80) Pharmacokinetics of Oral Vitamin C using Liposomal Form* To test whether plasma vitamin C levels, following oral doses in supplemented

More information

Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies. Michael A. Curran, Ph.D.

Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies. Michael A. Curran, Ph.D. Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies Michael A. Curran, Ph.D. MD Anderson Cancer Center Department of Immunology Disclosures I have research

More information

Understanding the mechanisms of asbestos related diseases

Understanding the mechanisms of asbestos related diseases University of Hawai i Cancer Center Understanding the mechanisms of asbestos related diseases Haining Yang, PhD Professor University of Hawai i Cancer Center Marker of exposure: Bilateral pleural plaques

More information

ulcer healing role 118 Bicarbonate, prostaglandins in duodenal cytoprotection 235, 236

ulcer healing role 118 Bicarbonate, prostaglandins in duodenal cytoprotection 235, 236 Subject Index Actin cellular forms 48, 49 epidermal growth factor, cytoskeletal change induction in mucosal repair 22, 23 wound repair 64, 65 polyamine effects on cytoskeleton 49 51 S-Adenosylmethionine

More information

CANCER THERAPEUTICS: A NOVEL APPROACH

CANCER THERAPEUTICS: A NOVEL APPROACH CANCER THERAPEUTICS: A NOVEL APPROACH Mary Dwyer, Ph.D. HBRI and ChemRegen, Inc. SCDMDG Meeting October 23, 212 Outline Introduction Hit, HBRI1: identification & characterization Leads, HBRI2 & HBRI3:

More information

Genetics and Cancer Ch 20

Genetics and Cancer Ch 20 Genetics and Cancer Ch 20 Cancer is genetic Hereditary cancers Predisposition genes Ex. some forms of colon cancer Sporadic cancers ~90% of cancers Descendants of cancerous cells all cancerous (clonal)

More information

Dr. C. Tom Kouroukis. New and upcoming treatments for Lymphoma

Dr. C. Tom Kouroukis. New and upcoming treatments for Lymphoma Dr. C. Tom Kouroukis New and upcoming treatments for Lymphoma New and upcoming treatments for Lymphoma Dr. Tom Kouroukis Hamilton Convention Centre November 23, 2013 Overview Importance and design of clinical

More information

Innate Immunity and Inflammation

Innate Immunity and Inflammation SITC Primer on Tumor Immunology and Biological Therapy of Cancer Innate Immunity and Inflammation Willem Overwijk, Ph.D. MD Anderson Cancer Center Center for Cancer Immunology Research Houston, TX www.allthingsbeautiful.com

More information

PI3K Background. The SignalRx R & D pipeline is shown below followed by a brief description of each program:

PI3K Background. The SignalRx R & D pipeline is shown below followed by a brief description of each program: PI3K Background The phosphatidylinositol 3-kinase (PI3K) pathway is a key cell signaling node whose dysregulation commonly results in the transformation of normal cells into cancer cells. The role of PI3K

More information

HDAC Inhibitors and PARP inhibitors. Suresh Ramalingam, MD Associate Professor Chief of Thoracic Oncology Emory University School of Medicine

HDAC Inhibitors and PARP inhibitors. Suresh Ramalingam, MD Associate Professor Chief of Thoracic Oncology Emory University School of Medicine HDAC Inhibitors and PARP inhibitors Suresh Ramalingam, MD Associate Professor Chief of Thoracic Oncology Emory University School of Medicine Histone Acetylation HAT Ac Ac Ac Ac HDAC Ac Ac Ac Ac mrna DACs

More information

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous Session8 Medical Genetics Cancer Genetics J avad Jamshidi F a s a U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 What is Cancer? Uncontrolled growth of cells Not all tumors

More information

Cytokine Arrays Reveal Black Ops Tactics of Tumor-induced Immunosuppression

Cytokine Arrays Reveal Black Ops Tactics of Tumor-induced Immunosuppression Cytokine Arrays Reveal Black Ops Tactics of Tumor-induced Immunosuppression Jarad J Wilson, Ph.D. Technical Support & Marketing Specialist Ruo-Pan Huang, MD, Ph.D. Founder and CEO What are Antibody Arrays?

More information

BIT 120. Copy of Cancer/HIV Lecture

BIT 120. Copy of Cancer/HIV Lecture BIT 120 Copy of Cancer/HIV Lecture Cancer DEFINITION Any abnormal growth of cells that has malignant potential i.e.. Leukemia Uncontrolled mitosis in WBC Genetic disease caused by an accumulation of mutations

More information

Medical Facts of Aronia. Steven Saulsbury M.D. February

Medical Facts of Aronia. Steven Saulsbury M.D. February Medical Facts of Aronia Steven Saulsbury M.D. February 29 2014 Medical Facts Facts and medical advice change with time Medical Facts Information increasingly media and market driven Confusing and often

More information

Molecular biology :- Cancer genetics lecture 11

Molecular biology :- Cancer genetics lecture 11 Molecular biology :- Cancer genetics lecture 11 -We have talked about 2 group of genes that is involved in cellular transformation : proto-oncogenes and tumour suppressor genes, and it isn t enough to

More information

NKTR-255: Accessing IL-15 Therapeutic Potential through Robust and Sustained Engagement of Innate and Adaptive Immunity

NKTR-255: Accessing IL-15 Therapeutic Potential through Robust and Sustained Engagement of Innate and Adaptive Immunity NKTR-255: Accessing IL-15 Therapeutic Potential through Robust and Sustained Engagement of Innate and Adaptive Immunity Peiwen Kuo Scientist, Research Biology Nektar Therapeutics August 31 st, 2018 Emerging

More information

Glioma cancer stem cells mediate immune suppression that can be reversed with STAT3 blockade

Glioma cancer stem cells mediate immune suppression that can be reversed with STAT3 blockade Glioma cancer stem cells mediate immune suppression that can be reversed with STAT3 blockade Jun Wei Department of Neurosurgery October 23, 2009 Immune suppression in Malignant Glioma Patients Mechanisms

More information

WHY TARGETTING SIGNALLING PATHWAYS?

WHY TARGETTING SIGNALLING PATHWAYS? WHY TARGETTING SIGNALLING PATHWAYS? Cancer cells are particularly sensitive to stress therefore sensitive to inhibition of their hyper activated signaling proteins the re instatement of lost tumor suppressors.

More information

Engineered Immune Cells for Cancer Therapy : Current Status and Prospects

Engineered Immune Cells for Cancer Therapy : Current Status and Prospects When Engineering Meets Immunology Engineered Immune Cells for Cancer Therapy : Current Status and Prospects Yong Taik Lim, Ph.D. Nanomedical Systems Laboratory (http://www.nanomedicalsystems.org) SKKU

More information

Introduction: 年 Fas signal-mediated apoptosis. PI3K/Akt

Introduction: 年 Fas signal-mediated apoptosis. PI3K/Akt Fas-ligand (CD95-L; Fas-L) Fas (CD95) Fas (apoptosis) 年 了 不 度 Fas Fas-L 力 不 Fas/Fas-L T IL-10Fas/Fas-L 不 年 Fas signal-mediated apoptosis 度降 不 不 力 U-118, HeLa, A549, Huh-7 MCF-7, HepG2. PI3K/Akt FasPI3K/Akt

More information

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated

More information

Treating patients affordably: personalized medicine in India

Treating patients affordably: personalized medicine in India economic Treating patients affordably: personalized medicine in India biologic B Moni Abraham Kuriakose MB ChB, MD, FDSRCS, FFDRCS, FRCS Ed., FRCS, Dip AB Professor and Director, Department of Surgical

More information

Nonspecific External Barriers skin, mucous membranes

Nonspecific External Barriers skin, mucous membranes Immune system Chapter 36 BI 103 Plant-Animal A&P Levels of Defense Against Disease Nonspecific External Barriers skin, mucous membranes Physical barriers? Brainstorm with a partner If these barriers are

More information

What is survivorship? Late effects of treatment. Concerns of survivorship

What is survivorship? Late effects of treatment. Concerns of survivorship Choices to enhance vitality!!!and survival!!!!!!!!! (and how to make it work in the real world)! What is survivorship? Multiple definitions! Anyone living with cancer at any stage since diagnosis! Anyone

More information

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases Abul K. Abbas UCSF Balancing lymphocyte activation and control Activation Effector T cells Tolerance Regulatory T cells

More information

Crosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea

Crosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Crosstalk between Adiponectin and IGF-IR in breast cancer Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Obesity Chronic, multifactorial disorder Hypertrophy and hyperplasia

More information

BIMM134 The Biology of Cancer SPRING 2015

BIMM134 The Biology of Cancer SPRING 2015 BIMM134 The Biology of Cancer SPRING 2015 Lectures: CENTR 214 Tuesdays/Thursdays, March 31 June 4 8:00 9:20 AM Instructor: Eric Bennett, Ph.D. email - e1bennett@ucsd.edu Office Hours: Tuesday and Thursday

More information

Objectives. Abbas Chapter 11: Immunological Tolerance. Question 1. Question 2. Question 3. Definitions

Objectives. Abbas Chapter 11: Immunological Tolerance. Question 1. Question 2. Question 3. Definitions Objectives Abbas Chapter 11: Immunological Tolerance Christina Ciaccio, MD Children s Mercy Hospitals and Clinics February 1, 2010 To introduce the concept of immunologic tolerance To understand what factors

More information

A Computational Assessment of the Robustness of Cancer Treatments with Respect to Immune Response Strength, Tumor Size and Resistance

A Computational Assessment of the Robustness of Cancer Treatments with Respect to Immune Response Strength, Tumor Size and Resistance International Journal of Tumor Therapy 2018, 7(1): 1-26 DOI: 10.5923/j.ijtt.20180701.01 A Computational Assessment of the Robustness of Cancer Treatments with Respect to Immune Response Strength, Tumor

More information

Signaling Apoptosis. Scott André Oakes, M.D. Dept. of Pathology Univ. of Calif-San Francisco. Cyt c Release BAX/BAK. Apoptosome Formation

Signaling Apoptosis. Scott André Oakes, M.D. Dept. of Pathology Univ. of Calif-San Francisco. Cyt c Release BAX/BAK. Apoptosome Formation Signaling Apoptosis Cyt c Release BAX/BAK Apoptosome Formation Caspase Activation Scott André Oakes, M.D. Dept. of Pathology Univ. of Calif-San Francisco Why do we need cell death? Sculpt Organs Control

More information

Immuno-Oncology. Axel Hoos, MD, PhD Senior Vice President, Oncology R&D. February 24, 2016

Immuno-Oncology. Axel Hoos, MD, PhD Senior Vice President, Oncology R&D. February 24, 2016 Immuno-Oncology Axel Hoos, MD, PhD Senior Vice President, Oncology R&D February 24, 216 GSK Pipeline Oncology R&D strategy Focusing on 3 areas fundamental to oncology Cancer Epigenetics Long-Term Survival

More information

Yong Wu, Ph.D. Division of Cancer Research and Training (DCRT) Charles R. Drew University of Medicine & Science

Yong Wu, Ph.D. Division of Cancer Research and Training (DCRT) Charles R. Drew University of Medicine & Science Yong Wu, Ph.D. Division of Cancer Research and Training (DCRT) Charles R. Drew University of Medicine & Science Jay Vadgama, Ph.D Chief, Division of Cancer Research and Training Background One in 8 women

More information

IDENTIFICATION OF BIOMARKERS FOR EARLY DIAGNOSIS OF BREAST CANCER"

IDENTIFICATION OF BIOMARKERS FOR EARLY DIAGNOSIS OF BREAST CANCER IDENTIFICATION OF BIOMARKERS FOR EARLY DIAGNOSIS OF BREAST CANCER" Edmond Marzbani, MD December 2, 2008 Early diagnosis of cancer Many solid tumors are potentially curable if diagnosed at an early stage

More information

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION Scott Abrams, Ph.D. Professor of Oncology, x4375 scott.abrams@roswellpark.org Kuby Immunology SEVENTH EDITION CHAPTER 13 Effector Responses: Cell- and Antibody-Mediated Immunity Copyright 2013 by W. H.

More information

Virchow s Hypothesis lymphorecticular infiltration of cancer reflected the origin of cancer at sites of inflammation

Virchow s Hypothesis lymphorecticular infiltration of cancer reflected the origin of cancer at sites of inflammation Virchow s Hypothesis 1863 lymphorecticular infiltration of cancer reflected the origin of cancer at sites of inflammation Barrett s esophagus/ Esophageal adenocarcinoma PSC / Cholangiocarcinoma Viral hepatitis

More information

Basis and Clinical Applications of Interferon

Basis and Clinical Applications of Interferon Interferon Therapy Basis and Clinical Applications of Interferon JMAJ 47(1): 7 12, 2004 Jiro IMANISHI Professor, Kyoto Prefectural University of Medicine Abstract: Interferon (IFN) is an antiviral substance

More information

Antitumor Activity of CUDC-305, a Novel Oral HSP90 Inhibitor, in Solid and Hematological Tumor Xenograft Models

Antitumor Activity of CUDC-305, a Novel Oral HSP90 Inhibitor, in Solid and Hematological Tumor Xenograft Models Antitumor Activity of CUDC-5, a Novel Oral HSP Inhibitor, in Solid and Hematological Tumor Xenograft Models Rudi Bao, MD/PhD April 1, 2 AACR 1th Annual Meeting 2 Experimental and Molecular Therapeutics

More information

CANCER IMMUNOPATHOLOGY. Eryati Darwin Faculty of Medicine Andalas University

CANCER IMMUNOPATHOLOGY. Eryati Darwin Faculty of Medicine Andalas University CANCER IMMUNOPATHOLOGY Eryati Darwin Faculty of Medicine Andalas University Padang 18 Mei 2013 INTRODUCTION Tumor: cells that continue to replicate, fail to differentiate into specialized cells, and become

More information

Instructor: Eric Bennett, Ph.D. - Office Hours: Tuesday and Thursday 3-4 pm, Natural Sciences Building, Room 5316

Instructor: Eric Bennett, Ph.D.  - Office Hours: Tuesday and Thursday 3-4 pm, Natural Sciences Building, Room 5316 BIMM134 The Biology of Cancer SPRING 2014 Lectures: WLH 2204 Tuesdays/Thursdays, April 1 June 5 8:00 9:20 AM Instructor: Eric Bennett, Ph.D. email - e1bennett@ucsd.edu Office Hours: Tuesday and Thursday

More information

Biologics Effects of Targeted Therapeutics

Biologics Effects of Targeted Therapeutics Report on the isbtc Mini-symposium on Biologics Effects of Targeted Therapeutics Michael B. Atkins, MD Beth Israel Deaconess Medical Center Louis Weiner, M.D. Fox Chase Cancer Center Report on the isbtc

More information

CYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION

CYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION CYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION What is Cytokine? Secreted popypeptide (protein) involved in cell-to-cell signaling. Acts in paracrine or autocrine fashion through specific cellular receptors.

More information

NKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies

NKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies NKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies Saul Kivimäe Senior Scientist, Research Biology Nektar Therapeutics NK Cell-Based Cancer Immunotherapy, September 26-27,

More information

The TNF & TNF receptor superfamillies

The TNF & TNF receptor superfamillies TNF Luca Tordella The TNF & TNF receptor superfamillies R.M.Locksley et al.,the TNF and TNF receptor superfamilies: integrating mammalian biology, Cell, 104:487,2001 Late 1800s: Dr William Coley at the

More information

Summary of Evolution and the Requirements for the Specific Cure of Cancer

Summary of Evolution and the Requirements for the Specific Cure of Cancer Summary of Evolution and the Requirements for the Specific Cure of Cancer The definition of cancer Cancer is defined by malignant behavior, (e.g. cell proliferation and invasiveness in an abnormal context.

More information

Chapter 9, Part 1: Biology of Cancer and Tumor Spread

Chapter 9, Part 1: Biology of Cancer and Tumor Spread PATHOPHYSIOLOGY Name Chapter 9, Part 1: Biology of Cancer and Tumor Spread I. Cancer Characteristics and Terminology Neoplasm new growth, involves the overgrowth of tissue to form a neoplastic mass (tumor).

More information

Deregulation of signal transduction and cell cycle in Cancer

Deregulation of signal transduction and cell cycle in Cancer Deregulation of signal transduction and cell cycle in Cancer Tuangporn Suthiphongchai, Ph.D. Department of Biochemistry Faculty of Science, Mahidol University Email: tuangporn.sut@mahidol.ac.th Room Pr324

More information

CANCER 1.7 M 609,000 26% 15.5 M 73% JUST THE FACTS. More Than 1,100 Cancer Treatments in Clinical Testing Offer Hope to Patients

CANCER 1.7 M 609,000 26% 15.5 M 73% JUST THE FACTS. More Than 1,100 Cancer Treatments in Clinical Testing Offer Hope to Patients CANCER MEDICINES IN DEVELOPMENT 2018 REPORT JUST THE FACTS MORE THAN 1.7 M ESTIMATED NEW CASES OF CANCER IN 2018 IN THE UNITED STATES MORE THAN 609,000 U.S. CANCER DEATHS ARE EXPECTED IN 2018 SINCE PEAKING

More information

Immunology Lecture 4. Clinical Relevance of the Immune System

Immunology Lecture 4. Clinical Relevance of the Immune System Immunology Lecture 4 The Well Patient: How innate and adaptive immune responses maintain health - 13, pg 169-181, 191-195. Immune Deficiency - 15 Autoimmunity - 16 Transplantation - 17, pg 260-270 Tumor

More information

IVC History, Cancer Research

IVC History, Cancer Research Riordan Clinic IVC Academy 5 IVC History, Cancer Research O (slides 1 40) Riordan Clinic 2018 High Dose Vitamin C Adjunctive Care for Cancer Patients IVC and Cancer Research Overview History & Research

More information

Discovery and Optimization of Inhibitors of STAT3 Activation for the Treatment of Squamous Cell Carcinoma of the Head and Neck

Discovery and Optimization of Inhibitors of STAT3 Activation for the Treatment of Squamous Cell Carcinoma of the Head and Neck Discovery and ptimization of Inhibitors of STAT3 Activation for the Treatment of Squamous Cell Carcinoma of the Head and Neck Feng Zhang Wipf Group Research Topic Seminar 02-09-2013 1 Feng Zhang @ Wipf

More information

Neoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath

Neoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath Neoplasia 18 lecture 6 Dr Heyam Awad MD, FRCPath ILOS 1. understand the role of TGF beta, contact inhibition and APC in tumorigenesis. 2. implement the above knowledge in understanding histopathology reports.

More information

National Cancer Institute 1

National Cancer Institute 1 Radioprotectors and Mitigators for Improving Radiotheapy July 31-Aug. 4, 2016 Pataje G. Prasanna, PH.D. C. Norman Coleman, M.D. Radiation Research Program National Cancer Institute/NIH E-mail: pat.prasanna@nih.gov

More information

What are Clinical Trials

What are Clinical Trials What are Clinical Trials Clinical Trials are systematic studies designed to discover and verify the effects and/or adverse reactions of drugs (pharmacodynamics) and the absorption, distribution, metabolism

More information

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation Cancer The fundamental defect is unregulated cell division. Properties of Cancerous Cells Altered growth and proliferation Loss of growth factor dependence Loss of contact inhibition Immortalization Alterated

More information

Kentucky Lung Cancer Research Program. Cycle 6 Grant Abstracts

Kentucky Lung Cancer Research Program. Cycle 6 Grant Abstracts Kentucky Lung Cancer Research Program Cycle 6 Grant Abstracts Principal Investigator Paula Bates, Ph.D. J. Scott Bryson, Ph.D. Donald Cohen, Ph.D., Alan Kaplan, Ph.D. Edward Hirschowitz, M.D. Robert Mitchell,

More information

Biobehavioral Pathways in Epithelial Ovarian Cancer

Biobehavioral Pathways in Epithelial Ovarian Cancer Biobehavioral Pathways in Epithelial Ovarian Cancer Susan K. Lutgendorf, Ph.D. Departments of Psychology, Obstetrics and Gynecology, and Urology and Holden Comprehensive Cancer Center University of Iowa

More information

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL. PhD THESIS

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL. PhD THESIS UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL PhD THESIS THE IMPORTANCE OF TUMOR ANGIOGENESIS IN CEREBRAL TUMOR DIAGNOSIS AND THERAPY ABSTRACT PhD COORDINATOR: Prof. univ. dr. DRICU Anica PhD

More information

Understanding the cellular targets of IMiDs and the relevance to clinical efficacy Dr. A. Keith Stewart

Understanding the cellular targets of IMiDs and the relevance to clinical efficacy Dr. A. Keith Stewart Understanding the cellular targets of IMiDs and the relevance to clinical efficacy Dr. A. Keith Stewart Scottsdale, Arizona Rochester, Minnesota Jacksonville, Florida Molecular Structure of Thalidomide,

More information

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM. !! www.clutchprep.com CONCEPT: OVERVIEW OF HOST DEFENSES The human body contains three lines of against infectious agents (pathogens) 1. Mechanical and chemical boundaries (part of the innate immune system)

More information

Novel Approaches to CAR-T Cell Platform

Novel Approaches to CAR-T Cell Platform Novel Approaches to CAR-T Cell Platform Vita Golubovskaya, Ph.D. Director, R&D Promab Biotechnologies 3 rd CAR-TCR Summit 2017 S E P T E M B E R 5-7 B O S T O N Novel Approaches To CAR-T Cell Platform

More information

The Immune System: The Mind Body Connection. Presented by Margaret Kemeny, Ph.D. Department of Psychiatry, University of California, San Francisco

The Immune System: The Mind Body Connection. Presented by Margaret Kemeny, Ph.D. Department of Psychiatry, University of California, San Francisco The Immune System: The Mind Body Connection Presented by Margaret Kemeny, Ph.D. Department of Psychiatry, University of California, San Francisco Psychoneuroimmunology Investigation of the bidirectional

More information

Contents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX

Contents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX Contents Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX 1 General Aspects of Signal Transduction and Cancer Therapy 1 1.1 General Principles of Signal Transduction

More information

BIO360 Fall 2013 Quiz 1

BIO360 Fall 2013 Quiz 1 BIO360 Fall 2013 Quiz 1 1. Examine the diagram below. There are two homologous copies of chromosome one and the allele of YFG carried on the light gray chromosome has undergone a loss-of-function mutation.

More information

METASTATIC COLORECTAL CANCER: TUMOR MUTATIONAL ANALYSIS AND ITS IMPACT ON CHEMOTHERAPY SUMA SATTI, MD

METASTATIC COLORECTAL CANCER: TUMOR MUTATIONAL ANALYSIS AND ITS IMPACT ON CHEMOTHERAPY SUMA SATTI, MD METASTATIC COLORECTAL CANCER: TUMOR MUTATIONAL ANALYSIS AND ITS IMPACT ON CHEMOTHERAPY SUMA SATTI, MD INTRODUCTION Second leading cause of cancer related death in the United States. 136,830 cases in 2014

More information

Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells

Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells ICI Basic Immunology course Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells Abul K. Abbas, MD UCSF Stages in the development of T cell responses: induction

More information

Author: Christine Thuyvan Dinh, M.D. Mentors: Thomas Van De Water, Ph.D., Fred Telischi, M.D., Simon Angeli, M.D.

Author: Christine Thuyvan Dinh, M.D. Mentors: Thomas Van De Water, Ph.D., Fred Telischi, M.D., Simon Angeli, M.D. Title: Effects of Dexamethasone on Cisplatin Ototoxicity In Vitro Author: Christine Thuyvan Dinh, M.D. Mentors: Thomas Van De Water, Ph.D., Fred Telischi, M.D., Simon Angeli, M.D. Acknowledgement: This

More information

Nursing s Role in the Management of New Oral Chemotherapy Agents

Nursing s Role in the Management of New Oral Chemotherapy Agents Nursing s Role in the Management of New Oral Chemotherapy Agents Mechelle Barrick BSN, RN, OCN, CCRP Clinical Research Nurse Coordinator Greater Baltimore Medical Center mbarrick@gbmc.org THE NURSES ROLE

More information

Phospho-AKT Sampler Kit

Phospho-AKT Sampler Kit Phospho-AKT Sampler Kit E 0 5 1 0 0 3 Kits Includes Cat. Quantity Application Reactivity Source Akt (Ab-473) Antibody E021054-1 50μg/50μl IHC, WB Human, Mouse, Rat Rabbit Akt (Phospho-Ser473) Antibody

More information

Immunology - Lecture 2 Adaptive Immune System 1

Immunology - Lecture 2 Adaptive Immune System 1 Immunology - Lecture 2 Adaptive Immune System 1 Book chapters: Molecules of the Adaptive Immunity 6 Adaptive Cells and Organs 7 Generation of Immune Diversity Lymphocyte Antigen Receptors - 8 CD markers

More information

Involvement of TLR4/STAT3 signaling in the antimelanoma effects of atractylenolide II. Fu Xiuqiong

Involvement of TLR4/STAT3 signaling in the antimelanoma effects of atractylenolide II. Fu Xiuqiong Involvement of TLR4/STAT3 signaling in the antimelanoma effects of atractylenolide II Fu Xiuqiong Melanoma fact Skin cancers Skin cancer deaths 2.3% 75% Melanoma Non-melanoma skin cancers ----American

More information

THE ROLE OF TARGETED THERAPY AND IMMUNOTHERAPY IN THE TREATMENT OF ADVANCED CERVIX CANCER

THE ROLE OF TARGETED THERAPY AND IMMUNOTHERAPY IN THE TREATMENT OF ADVANCED CERVIX CANCER Gynecologic Cancer InterGroup Cervix Cancer Research Network THE ROLE OF TARGETED THERAPY AND IMMUNOTHERAPY IN THE TREATMENT OF ADVANCED CERVIX CANCER Linda Mileshkin, Medical Oncologist Peter MacCallum

More information

Generation of post-germinal centre myeloma plasma B cell.

Generation of post-germinal centre myeloma plasma B cell. Generation of post-germinal centre myeloma. DNA DAMAGE CXCR4 Homing to Lytic lesion activation CD38 CD138 CD56 Phenotypic markers Naive Secondary lymphoid organ Multiple myeloma is a malignancy of s caused

More information

T Cell Effector Mechanisms I: B cell Help & DTH

T Cell Effector Mechanisms I: B cell Help & DTH T Cell Effector Mechanisms I: B cell Help & DTH Ned Braunstein, MD The Major T Cell Subsets p56 lck + T cells γ δ ε ζ ζ p56 lck CD8+ T cells γ δ ε ζ ζ Cα Cβ Vα Vβ CD3 CD8 Cα Cβ Vα Vβ CD3 MHC II peptide

More information

Adaptive Immune Response Day 2. The Adaptive Immune Response

Adaptive Immune Response Day 2. The Adaptive Immune Response Adaptive Immune Response Day 2 Chapter 16 The Adaptive Immune Response 1 The B cell receptor vs. the T cell receptor. The B cell receptor vs. the T cell receptor. 2 Which T cells have CD4 and which have

More information

MOLECULAR BASIS OF ONCOGENESIS

MOLECULAR BASIS OF ONCOGENESIS MOLECULAR BASIS OF ONCOGENESIS MUDr. Jiří Vachtenheim, CSc. 1 Cell processes which result also in cell cycle effects. Differentiation. Differentiated cells are usually in the G0 phase of the cell cycle.

More information

"BRCAness," PARP and the Triple-Negative Phenotype

BRCAness, PARP and the Triple-Negative Phenotype "BRCAness," PARP and the Triple-Negative Phenotype Prof Alan Ashworth, FRS Disclosures for Professor Alan Ashworth, FRS Consulting Agreements GlaxoSmithKline, Pfizer Inc Patent AstraZeneca Pharmaceuticals

More information

Karyotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl

Karyotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl Chapt. 18 Cancer Molecular Biology of Cancer Student Learning Outcomes: Describe cancer diseases in which cells no longer respond Describe how cancers come from genomic mutations (inherited or somatic)

More information

Apoptosis Oncogenes. Srbová Martina

Apoptosis Oncogenes. Srbová Martina Apoptosis Oncogenes Srbová Martina Cell Cycle Control point Cyclin B Cdk1 Cyclin D Cdk4 Cdk6 Cyclin A Cdk2 Cyclin E Cdk2 Cyclin-dependent kinase (Cdk) have to bind a cyclin to become active Regulation

More information

Self Tolerance and MHC Restriction. Dr. Issa Abu-Dayyeh

Self Tolerance and MHC Restriction. Dr. Issa Abu-Dayyeh Self Tolerance and MHC Restriction Dr. Issa Abu-Dayyeh How do we teach B and T cells not to recognise self antigens as dangerous? How do we restrict T cells to recognise only Ags presented on a self MHC

More information